LdtMt2
From Proteopedia
| Line 6: | Line 6: | ||
<scene name='81/817533/Domaina/1'>DomainA</scene> | <scene name='81/817533/Domaina/1'>DomainA</scene> | ||
<scene name='81/817533/Domainb/1'>DomainB</scene> | <scene name='81/817533/Domainb/1'>DomainB</scene> | ||
| + | <scene name='81/817533/Domaincd/1'>DomainCD</scene> | ||
Revision as of 14:20, 10 June 2019
Overview
The L,D-transpeptidase LdtMt2 is an enzyme that catalyzes the formation of peptidoglycan crosslinking in Mycobaterium tuberculosis. Formation of the most common type of crosslink in peptidoglycan, the (D,D) 4 -> 3 linkage, is catalyzed by the D,D-transpeptidase. These enzymes generate 4 -> 3 transpeptidase linkages between the fourth amino acid (D-alanine) of one chain and the third amino acid (meso-diaminopimelic acid) of an adjacent chain. A second type of crosslink, the (L,D) 3 -> 3 linkage is catalysed by L,D-transpeptidases such as Mtb L,D-transpeptidase LdtMt2 of Mycobaterium tuberculosis. These enzymes transfer the peptide bond between the third residue (meso-diaminopimelic acid) of a tetrapeptide donor stem to the side-chain amide group of the third residue (meso-diaminopimelic acid) of an adjacent acceptor stem. In both types of transpeptidases, the catalysis proceeds by a two-step mechanism: acylation of the enzyme by the penultimate peptide of the donor stem with the release of the stem C-terminal residue, followed by deacylation of this acyl-enzyme intermediate by an acceptor stem. This is a default text for your page LdtMt2. Click above on edit this page to modify. Be careful with the < and > signs. You may include any references to papers as in: the use of JSmol in Proteopedia [1] or to the article describing Jmol [2] to the rescue.
FunctionThe final step of peptidoglycan biosynthesis in bacteria involves the formation of crosslinking. The D,D transpeptidase catalyzes the formation of crosslinking. B-lactams antibiotics such as penicillin inhibit this D,D transpeptidases. But it was found that Mycobacterium tuberculosis was resistant to these antibiotics. This happens because mycobacteria rely mostly on L,D transpeptidase for biosynthesis and maintenance of their peptidoglycan layer. Loss of L,D transpeptidase in Mycobacterium tuberculosis Ldt_Mt2 result in altered cell size, growth and virulence as well as increased susceptibility to B-lactams antibiotics StructureThe LdtMt2 precursor consists of 408 amino acid residues that form the transmembrane domain (Met1-Ala34) and the chain of the enzyme (Cys35-Ala408), which can be divided into three domains: two non-catalytic Ig-like domains A and B (residues Ala55-Ser147 and Pro148- Gly250, respectively) and the catalytic domain C (residues Asp251-Ala408) with transpeptidase activity. The two non-catalytic domains display a variant to the immunoglobulin fold built up by a sandwich of two antiparallel sheets. The C-terminal consists of the catalytic domain of the typical ErfK/YbiS/ YhnG fold. In LdtMt2 the active site is located under a lid formed by a pair of antiparallel -strands and their connecting loop (residues 298–324) Active siteThe catalytic site of LdtMt2 is located at the entrance of a narrow tunnel connecting two cavities and there is a lid covering the active site formed by a pair of antiparallel B-strands and their connecting loop. The large hydrophobic residues of the lid (Tyr298, Tyr308 and Tyr318) and the residues surrounding the entrance to the active site (Tyr330, Phe334 and Trp340) contribute to the closure and to the exclusion of solvent, which may support efficient catalysis. At one end of the tunnel Tyr318 and the carbonyl group of Gly332 recognize the D chiral center of the meso-diaminopimelic acid side chain, making H bonds to its carboxylate and amide group. At the other end, the L chiral center is surrounded by an ‘‘anion hole’’ formed by the backbone NH group of residues 352–354 at the C terminus of loop Lc. In this position, the acyl group of the m-DAP L chiral center is within reach of Cys354. His336 is close and ready to accept a H+ from Cys354. The cysteine thiolate formed by this H+ abstraction attacks the acyl carbon and forms a tetrahedral intermediate stabilized by the ‘‘anion hole’’ and by the just protonated His336. After the intermediate thioester formation and protonation by His336, D-Ala4 is released. Then another peptide stem can enter the catalytic site and bind to active site residues with the side-chain amide of the mDAP residue. Nucleophilic attack by this amine group forms the new peptide bond that crosslinks the two stems with release and protonation of the cysteine thiolate by His336. The last step in the transpeptidation reaction requires that donor and acceptor peptidoglycan stems both be at the catalytic site for the reaction to occur. Structural highlightsReferences
| ||||||||||||
